BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11713800)

  • 1. Modified oligonucleotides--synthesis, properties and applications.
    Lyer RP; Roland A; Zhou W; Ghosh K
    Curr Opin Mol Ther; 1999 Jun; 1(3):344-58. PubMed ID: 11713800
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of pyrrolidine-based oxy-peptide nucleic acids that contain four bases and their properties.
    Kitamatsu M; Shigeyasu M; Okada T; Saitoh M; Sisido M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):227-8. PubMed ID: 17150561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of second-generation antisense oligonucleotides.
    Dean NM; Griffey RH
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):229-33. PubMed ID: 9212916
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of the extent of thiolation and introduction of phosphorothioate internucleotide linkages on the anti-HIV activity of Suligovir [(s4dU)35].
    Horváth A; Beck Z; Bardos TJ; Dunn JA; Aradi J
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5321-3. PubMed ID: 16920358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereocontrolled phosphorothioate synthesis using chiral phosphite triesters.
    Mizuguchi M; Yomogida Y; Makino K
    Nucleic Acids Symp Ser; 1995; (34):113-4. PubMed ID: 8841578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative substitution of boranephosphonate diesters as a route to post-synthetically modified DNA.
    Paul S; Roy S; Monfregola L; Shang S; Shoemaker R; Caruthers MH
    J Am Chem Soc; 2015 Mar; 137(9):3253-64. PubMed ID: 25679520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA and LNA oligonucleotides containing N2'-functionalised derivatives of 2'-amino-2'-deoxyuridine.
    Kalra N; Parlato MC; Parmar VS; Wengel J
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3166-9. PubMed ID: 16621554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Backbone modification of nucleic acids: synthesis, structure and therapeutic applications.
    Micklefield J
    Curr Med Chem; 2001 Aug; 8(10):1157-79. PubMed ID: 11472234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-oligonucleotides with anionic phosphodiester and cationic phosphoramidate linkages enhanced stability of DNA triple helix.
    Ehrenmann F; Vasseur JJ; Debart F
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):797-9. PubMed ID: 11563118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and properties of oligonucleotide analogs having phosphoramidate linkages.
    Kitamura M; Ozaki H; Yamana K; Shimidzu T
    Nucleic Acids Symp Ser; 1990; (22):65-6. PubMed ID: 2101917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of DNA-oligonucleotides damaged by arylamine-modified 2'-deoxyguanosine.
    Böge N; Szombati Z; Meier C
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):705-8. PubMed ID: 18066884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligonucleoside boranophosphate (borane phosphonate).
    Shaw BR; Madison J; Sood A; Spielvogel BF
    Methods Mol Biol; 1993; 20():225-43. PubMed ID: 8242139
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis of monomers bearing at the 2'-position cyanomethoxycarbonyl group for phosphoramidite oligonucleotide synthesis.
    Vasilyeva SV; Abramova TV; Silnikov VN
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):993-8. PubMed ID: 15560092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and properties of 2'-modified-4'-thioRNA.
    Takahashi M; Minakawa N; Matsuda A
    Nucleic Acids Symp Ser (Oxf); 2008; (52):327-8. PubMed ID: 18776386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly stable DNA triplexes formed with cationic phosphoramidate pyrimidine alpha-oligonucleotides.
    Michel T; Debart F; Heitz F; Vasseur JJ
    Chembiochem; 2005 Jul; 6(7):1254-62. PubMed ID: 15912553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorothioate nucleotides and oligonucleotides - recent progress in synthesis and application.
    Guga P; Koziołkiewicz M
    Chem Biodivers; 2011 Sep; 8(9):1642-81. PubMed ID: 21922655
    [No Abstract]   [Full Text] [Related]  

  • 17. Telomerase inhibitors--oligonucleotide phosphoramidates as potential therapeutic agents.
    Gryaznov S; Pongracz K; Matray T; Schultz R; Pruzan R; Aimi J; Chin A; Harley C; Shea-Herbert B; Shay J; Oshima Y; Asai A; Yamashita Y
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):401-10. PubMed ID: 11563055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A platform for both solid-phase peptide nucleic acid oligomer synthesis and subsequent in situ detection and quantification of nucleic acid sequences.
    McCairn MC; Hughes MD; Hine AV; Sutherland AJ
    J Comb Chem; 2006; 8(5):639-42. PubMed ID: 16961397
    [No Abstract]   [Full Text] [Related]  

  • 19. Nucleotide insertion and bypass synthesis of pyrene- and BODIPY-modified oligonucleotides by DNA polymerases.
    Wanninger-Weiss C; Di Pasquale F; Ehrenschwender T; Marx A; Wagenknecht HA
    Chem Commun (Camb); 2008 Mar; (12):1443-5. PubMed ID: 18338050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards the synthesis of inosine building blocks for the preparation of oligonucleotides with hydrophobic alkyl chains between the nucleotide units.
    Köstler K; Rosemeyer H
    Molecules; 2009 Oct; 14(11):4326-36. PubMed ID: 19924067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.